Evaluation of the COPD Assessment Test and GOLD patient types: A cross-sectional analysis

International Journal of COPD

Volumn 10, Issue , 2015, Pages 975-984

  Lopez Campos, Jose Luis ^a,b   Fernandez Villar, Alberto ^c   Calero Acuña, Carmen ^a   Represas Represas, Cristina ^c   Lopez Ramírez, Cecilia ^a   Fernández, Virginia Leiro ^c   Soler Cataluña, Juan Jose ^b,d   Casamor, Ricard ^e  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Hospital Meixoeiro Edificio Anexo   (Spain)

^d HOSPITAL ARNAU DE VILANOVA   (Spain)

^e S A   (Spain)

Author keywords

Chronic obstructive pulmonary diseases; Comorbidities; Multidimensional evaluation

Indexed keywords

AGED; ARTICLE; ASSESSMENT OF HUMANS; CHARLSON COMORBIDITY INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; COPD ASSESSMENT TEST; CROSS-SECTIONAL STUDY; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; EVALUATION STUDY; FEMALE; FUNCTIONAL DISEASE; GLOBAL INITIATIVE FOR OBSTRUCTIVE LUNG DISEASE; HUMAN; INSTRUMENT VALIDATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH COUNCIL SCALE; OBSERVATIONAL STUDY; PATIENT ASSESSMENT; PROGRAM EVALUATION; QUESTIONNAIRE; RESPIRATORY TRACT DISEASE ASSESSMENT; SCORING SYSTEM; SMOKING; SPIROMETRY; DECISION SUPPORT SYSTEM; DISEASE COURSE; LUNG; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SPAIN; STATISTICAL MODEL;

AGED; COMORBIDITY; CROSS-SECTIONAL STUDIES; DECISION SUPPORT TECHNIQUES; DISEASE PROGRESSION; DYSPNEA; FEMALE; HUMANS; LINEAR MODELS; LUNG; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SPAIN; SPIROMETRY; SURVEYS AND QUESTIONNAIRES;

EID: 84933506129     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S82781     Document Type: Article

References (27)

1. Miravitlles M, Soler-Cataluña JJ, Calle M, et al. Spanish guideline for COPD (GesEPOC). Update 2014. Arch Bronconeumol. 2014;50 Suppl 1:S1-S16.
2. Lopez-Campos JL, Bustamante V, Muñoz X, Barreiro E. Moving towards patient-centered medicine for COPD management: multidimensional approaches versus phenotype-based medicine-a critical view. COPD. 2014;11(5):591-602.
3. Vestbo J, Hurd SS, Rodriguez-Roisin R. The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD)-why and what? Clin Respir J. 2012;6(4):208-214.
4. Chrystyn H, Small M, Milligan G, Higgins V, Gil EG, Estruch J. Impact of patients' satisfaction with their inhalers on treatment compliance and health status in COPD. Respir Med. 2014;108(2):358-365.
5. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648-654.
6. Jones PW, Tabberer M, Chen WH. Creating scenarios of the impact of COPD and their relationship to COPD Assessment Test (CAT™) scores. BMC Pulm Med. 2011;11:42.
7. Feliz-Rodriguez D, Zudaire S, Carpio C, et al. Evolution of the COPD Assessment Test score during chronic obstructive pulmonary disease exacerbations: determinants and prognostic value. Can Respir J. 2013; 20(5):e92-e97.
8. Miyazaki M, Nakamura H, Chubachi S, et al; Keio COPD Comorbidity Research (K-CCR) Group. Analysis of comorbid factors that increase the COPD assessment test scores. Respir Res. 2014;15:13.
9. Dodd JW, Marns PL, Clark AL, et al. The COPD Assessment Test (CAT): short-and medium-term response to pulmonary rehabilitation. COPD. 2012;9(4):390-394.
10. Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. Significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J. 1959;2(5147):257-266.
11. Jones PW, Adamek L, Nadeau G, Banik N. Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification. Eur Respir J. 2013;42(3):647-654.
12. Dal Negro RW, Bonadiman L, Turco P. Sensitivity of the COPD assessment test (CAT questionnaire) investigated in a population of 681 consecutive patients referring to a lung clinic: the first Italian specific study. Multidiscip Respir Med. 2014;9(1):15.
13. Fernández-Villar A, López-Campos JL, Represas Represas C, et al. Factors associated with inadequate diagnosis of COPD. On-sint cohort analysis. Int J COPD. In press 2015.
14. Miravitlles M, Soriano JB, García-Río F, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax. 2009;64(10):863-868.
15. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347-365.
16. Soriano JB, Alfageme I, Almagro P, et al. Distribution and prognostic validity of the new Global Initiative for Chronic Obstructive Lung Disease grading classification. Chest. 2013;143(3):694-702.
17. Vestbo J, Anderson W, Coxson HO, et al; ECLIPSE Investigators. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J. 2008;31(4):869-873.
18. de Torres JP, Marin JM, Martinez-Gonzalez C, et al; COPD History Assessment in Spain (CHAIN) Cohort*. Clinical application of the COPD assessment test: longitudinal data from the COPD History Assessment in Spain (CHAIN) cohort. Chest. 2014;146(1):111-122.
19. Lee SD, Huang MS, Kang J, et al; Investigators of the Predictive Ability of CAT in Acute Exacerbations of COPD (PACE) Study. The COPD assessment test (CAT) assists prediction of COPD exacerbations in high-risk patients. Respir Med. 2014;108(4):600-608.
20. Horita N, Yomota M, Sasaki M, et al. Evaluation of the chronic obstructive pulmonary disease assessment test in Japanese outpatients. Clin Respir J. 2014;8(2):213-219.
21. Gupta N, Pinto LM, Morogan A, Bourbeau J. The COPD assessment test: a systematic review. Eur Respir J. 2014;44(4):873-884.
22. Gruffydd-Jones K, Marsden HC, Holmes S, et al. Utility of COPD Assessment Test (CAT) in primary care consultations: a randomised controlled trial. Prim Care Respir J. 2013;22(1):37-43.
23. Agusti A, Edwards LD, Celli B, et al; ECLIPSE Investigators. Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort. Eur Respir J. 2013;42(3):636-646.
24. Price DB, Baker CL, Zou KH, Higgins VS, Bailey JT, Pike JS. Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classification. Int J Chron Obstruct Pulmon Dis. 2014;9:551-561.
25. López Campos JL, Calero C. Questionnaires in multidimensional assessment of chronic obstructive pulmonary disease: two sides of the same coin. Arch Bronconeumol. 2014;50(7):265-266.
26. Divo M, Cote C, de Torres JP, et al; BODE Collaborative Group. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(2):155-161.
27. Groll DL, To T, Bombardier C, Wright JG. The development of a comorbidity index with physical function as the outcome. J Clin Epidemiol. 2005;58(6):595-602.